VEGFA and COVID-19: Furthermore, VEGF, which is an agonist of the NRP-1 receptor, is elevated in COVID-19 due to the blocking of VEGF/NRP-1 signaling by the spike protein of SARS-CoV-2, with subsequent development of neuropathic pain [95].